A review on chitosan and its development as pulmonary particulate anti-infective and anti-cancer drug carriers

[Display omitted] •Chitosan exhibits mucoadhesive/permeation enhancement/cell targeting attributes.•It possesses anti-microbial and anti-cancer properties.•Pulmonary chitosan based particulate drug carriers are effective against infection and cancer.•Inhalation of nanodrug carrier is promoted by its...

Full description

Saved in:

Bibliographic Details
Published in:	Carbohydrate polymers Vol. 250; p. 116800
Main Authors:	Rasul, Ruhisy Mohd, Tamilarasi Muniandy, M., Zakaria, Zabliza, Shah, Kifayatullah, Chee, Chin Fei, Dabbagh, Ali, Rahman, Noorsaadah Abd, Wong, Tin Wui
Format:	Journal Article
Language:	English
Published:	England Elsevier Ltd 15-12-2020
Subjects:	Anti-Infective Agents - chemistry Anti-Infective Agents - pharmacology Anti-Infective Agents - therapeutic use Antineoplastic Agents - chemistry Antineoplastic Agents - pharmacology Antineoplastic Agents - therapeutic use Betacoronavirus - isolation & purification Biocompatible Materials - chemistry Cancer Cell Survival - drug effects Chitosan Chitosan - analogs & derivatives Coronavirus Infections - drug therapy Coronavirus Infections - pathology Coronavirus Infections - virology COVID-19 Drug Carriers - chemistry Humans Infection Lung Neoplasms - pathology Nanoparticle Pandemics Pneumonia, Viral - drug therapy Pneumonia, Viral - pathology Pneumonia, Viral - virology Pulmonary drug delivery SARS-CoV-2 Infection Pulmonary drug delivery Chitosan Nanoparticle Cancer
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	[Display omitted] •Chitosan exhibits mucoadhesive/permeation enhancement/cell targeting attributes.•It possesses anti-microbial and anti-cancer properties.•Pulmonary chitosan based particulate drug carriers are effective against infection and cancer.•Inhalation of nanodrug carrier is promoted by its development as microscale particle.•Anti-HCoV chitosan derivatives are new carrier material of interest with therapeutic property. Chitosan, as a biodegradable and biocompatible polymer, is characterized by anti-microbial and anti-cancer properties. It lately has received a widespread interest for use as the pulmonary particulate backbone materials of drug carrier for the treatment of infectious disease and cancer. The success of chitosan as pulmonary particulate drug carrier is a critical interplay of their mucoadhesive, permeation enhancement and site/cell-specific attributes. In the case of nanocarriers, various microencapsulation and micro-nano blending systems have been devised to equip them with an appropriate aerodynamic character to enable efficient pulmonary aerosolization and inhalation. The late COVID-19 infection is met with acute respiratory distress syndrome and cancer. Chitosan and its derivatives are found useful in combating HCoV and cancer as a function of their molecular weight, substituent type and its degree of substitution. The interest in chitosan is expected to rise in the next decade from the perspectives of drug delivery in combination with its therapeutic performance.
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23
ISSN:	0144-8617 1879-1344 1879-1344
DOI:	10.1016/j.carbpol.2020.116800